Evaluation of Urinary Oxalate Levels in Patients Receiving Gastrointestinal Lipase Inhibitor

Abstract

Our results suggest that increased intestinal absorption of dietary oxalate due to this type of medication in obese patients could make a substantial contribution to urinary oxalate excretion and may increase the risk of stone formation.